About Wavelength Pharmaceuticals
Wavelength Pharmaceuticals is a company based in Petah Tikva (Israel) founded in 1987 was acquired by SK Capital in November 2017. The company has 39 employees as of April 07, 2024. Wavelength Pharmaceuticals has completed 1 acquisition, including Vanamali Organics. Wavelength Pharmaceuticals operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Petah Tikva, Israel
- Employees 39 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Monolom India Pharma Private Limited
- Date of Incorporation 27 Oct, 2017
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$1.87 M (USD)19.92as on Mar 31, 2022
-
Net Profit
$183.32 K (USD)21.7as on Mar 31, 2022
-
EBITDA
$551.88 K (USD)1.58as on Mar 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
39
as on Apr 07, 2024
- Investments & Acquisitions
-
Acquired by
SK Capital
(Nov 01, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Wavelength Pharmaceuticals
Detailed funding history for Wavelength Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Wavelength Pharmaceuticals
Wavelength Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SK Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A global private investment firm focused on specialty sectors.
|
Locked | Locked | Locked |
Investor details for Wavelength Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wavelength Pharmaceuticals
Wavelength Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Vanamali Organics.
Investment portfolio details for Wavelength Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of research and development, process development, and manufacturing services
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for Wavelength Pharmaceuticals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Wavelength Pharmaceuticals
Detailed financials for Wavelength Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wavelength Pharmaceuticals Comparisons
Peer comparison for Wavelength Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Wavelength Pharmaceuticals
Wavelength Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Wavelength Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wavelength Pharmaceuticals
Complete news archive for Wavelength Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wavelength Pharmaceuticals
Wavelength Pharmaceuticals was founded in 1987.
Wavelength Pharmaceuticals is headquartered in Petah Tikva, Israel. It is registered at Petah Tikva, Central District, Israel.
As of Apr 07, 2024, the latest employee count at Wavelength Pharmaceuticals is 39.
Annual revenue of Wavelength Pharmaceuticals is $1.87M as on Mar 31, 2022.
Wavelength Pharmaceuticals was founded in 1987 and is located in Petah Tikva, Israel. Active pharmaceutical ingredients and finished dosage forms are produced, including semi-solid topicals, transdermals, parenteral solutions, oral solids, and liquids. Therapeutic areas covered include oncology, allergic rhinitis, neurological disorders, and antihyperlipidemic treatments. Ongoing developments focus on antiepileptic, dermatological, and respiratory products within the pharmaceutical sector.
Wavelength Pharmaceuticals's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Wavelength Pharmaceuticals has made 1 acquisition, including Vanamali Organics.
Wavelength Pharmaceuticals has 1 investor. Key investors include SK Capital.